In an article, published in an article, once mentioned the application of 10200-59-6, Name is 2-Thiazolecarboxaldehyde,molecular formula is C4H3NOS, is a conventional compound. this article was the specific content is as follows.Computed Properties of C4H3NOS
The invention relates to compounds of formula whereinR1 is a 5 or 6 membered heteroaryl group, containing 1 to 3 heteroatoms, selected from N, O or S, and which groups are optionally substituted by one or two substituents, which are lower alkyl, ?(CH2)nOH, halogen or lower alkoxy, and wherein the heteroaryl groups may be optionally linked to the pyrazole ring via an alkylene or alkenyl group, or isphenyl, optionally substituted by one or two substituents being lower alkyl, hydroxy-lower alkyl, halogen, hydroxy or lower alkoxy or is?O(CH2)n,phenyl, benzofuryl, indolyl or benzothiophenyl, or is?S-lower alkyl;R2 and R4 are independently from each other hydrogen, cyano or ?S(O)2-phenyl;R3 is hydrogen, halogen or isa 5 or 6 membered heteroaryl group, containing 1 to 3 heteroatoms, selected from N, O or S, and which groups are optionally substituted by one or two substituents, which are lower alkyl, ?(CH2)n-aryl, hydroxy, halogen, lower alkoxy, morpholinyl, amino, lower alkylamino or ?C(O)NR?2, and wherein R? is lower alkyl or hydrogen, or isphenyl, optionally substituted by one or two substituents being halogen, lower alkyl, lower alkoxy, amino, di-lower alkyl amino, CF3, ?OCF3, ?NHC(O)lower alkyl, cyano, ?C(O)-lower alkyl, ?C(O)O-lower alkyl, ?S-lower alkyl, ?S(O)2NH-phenyl, ?S(O)2-methylpiperazinyl; or is?NR?R?, wherein R? and R? are independently from each other hydrogen, ?(CH2)nphenyl, which phenyl ring is optionally substituted by halogen or lower alkoxy, ?CH(lower alkyl)-phenyl, indan-1-yl, 1,2,3,4-tetrahydro-naphthalen, or cycloalkyl; or is?O-phenyl, which phenyl ring is optionally substituted by halogen, lower alkyl or lower alkoxy, ?O-tetrahydronaphthalenyl or ?O?CH2-6-methyl-pyridin-2-yl; or is-benzo[1,3]dioxolyl, -1H-indol-5-yl, naphthyl, benzofuran-2-yl, 1,3,4,9-tetrahydro-b-carbolin-2-yl, piperidin-1-yl, pyrrolidin-1-yl, piperazin-4-yl-methyl or morpholinyl;R5 is ?NR2, wherein R may be the same or different and is hydrogen, lower alkyl, phenyl, benzyl, ?CO-lower alkyl, ?CO-lower alkoxy, -lower alkenyl, ?CO(CH2)n-phenyl or ?COO(CH2)n-phenyl, wherein the phenyl ring is optionally substituted by CF3, lower alkoxy, halogen or lower alkyl, ?CO(CH2)3-NHCO-lower alkoxy, ?(CH2)n-phenyl, wherein the phenyl ring is optionally substituted by lower alkoxy, CF3 or halogen, or is 4,5-dihydro-1H-imidazol-2-yl-benzoic acid, 1,4,5,6-tetrahydro-pyrimidin-2-yl-benzoic acid or 4,5,6,7-tetrahydro-1H-[1,3]diazepin-2-yl-benzoic acid;n is 0-4and their pharmaceutically acceptable salts
The invention relates to compounds of formula whereinR1 is a 5 or 6 membered heteroaryl group, containing 1 to 3 heteroatoms, selected from N, O or S, and which groups are optionally substituted by one or two substituents, which are lower alkyl, ?(CH2)nOH, halogen or lower alkoxy, and wherein the heteroaryl groups may be optionally linked to the pyrazole ring via an alkylene or alkenyl group, or isphenyl, optionally substituted by one or two substituents being lower alkyl, hydroxy-lower alkyl, halogen, hydroxy or lower alkoxy or is?O(CH2)n,phenyl, benzofuryl, indolyl or benzothiophenyl, or is?S-lower alkyl;R2 and R4 are independently from each other hydrogen, cyano or ?S(O)2-phenyl;R3 is hydrogen, halogen or isa 5 or 6 membered heteroaryl group, containing 1 to 3 heteroatoms, selected from N, O or S, and which groups are optionally substituted by one or two substituents, which are lower alkyl, ?(CH2)n-aryl, hydroxy, halogen, lower alkoxy, morpholinyl, amino, lower alkylamino or ?C(O)NR?2, and wherein R? is lower alkyl or hydrogen, or isphenyl, optionally substituted by one or two substituents being halogen, lower alkyl, lower alkoxy, amino, di-lower alkyl amino, CF3, ?OCF3, ?NHC(O)lower alkyl, cyano, ?C(O)-lower alkyl, ?C(O)O-lower alkyl, ?S-lower alkyl, ?S(O)2NH-phenyl, ?S(O)2-methylpiperazinyl; or is?NR?R?, wherein R? and R? are independently from each other hydrogen, ?(CH2)nphenyl, which phenyl ring is optionally substituted by halogen or lower alkoxy, ?CH(lower alkyl)-phenyl, indan-1-yl, 1,2,3,4-tetrahydro-naphthalen, or cycloalkyl; or is?O-phenyl, which phenyl ring is optionally substituted by halogen, lower alkyl or lower alkoxy, ?O-tetrahydronaphthalenyl or ?O?CH2-6-methyl-pyridin-2-yl; or is-benzo[1,3]dioxolyl, -1H-indol-5-yl, naphthyl, benzofuran-2-yl, 1,3,4,9-tetrahydro-b-carbolin-2-yl, piperidin-1-yl, pyrrolidin-1-yl, piperazin-4-yl-methyl or morpholinyl;R5 is ?NR2, wherein R may be the same or different and is hydrogen, lower alkyl, phenyl, benzyl, ?CO-lower alkyl, ?CO-lower alkoxy, -lower alkenyl, ?CO(CH2)n-phenyl or ?COO(CH2)n-phenyl, wherein the phenyl ring is optionally substituted by CF3, lower alkoxy, halogen or lower alkyl, ?CO(CH2)3-NHCO-lower alkoxy, ?(CH2)n-phenyl, wherein the phenyl ring is optionally substituted by lower alkoxy, CF3 or halogen, or is 4,5-dihydro-1H-imidazol-2-yl-benzoic acid, 1,4,5,6-tetrahydro-pyrimidin-2-yl-benzoic acid or 4,5,6,7-tetrahydro-1H-[1,3]diazepin-2-yl-benzoic acid;n is 0-4and their pharmaceutically acceptable salts
Do you like my blog? If you like, you can also browse other articles about this kind. Computed Properties of C4H3NOS. Thanks for taking the time to read the blog about 10200-59-6
Reference£º
Thiazole | C3H4207NS – PubChem,
Thiazole | chemical compound | Britannica